As MDM4 gene amplification is a characteristic of both Ewing and osteosarcoma8, this study assessed the therapeutic potential of XI-006, a small molecule thought to attenuate MDM4 promoter activity, for the treatment of sarcoma. Here, MDM4 is linked to sarcoma.